BioSpace News Archive

Eye care professionals from Latin America have come to Texas for two weeks of training on board the world’s only Flying Eye Hospital

Invicro LLC, a Konica Minolta Company announced it has entered into a strategic research partnership with industry leading pathologist, Dr. David Rimm, MD, PhD, at The Yale University School of Medicine to advance the development of Quanticell, Konica Minolta’s proprietary tissue biomarker detection technology.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat Depression (DTD)

Cutting-edge therapies for depression are currently in high demand. Depression affects more than 264 million people worldwide. “Spravato” is the latest technique being utilized to counteract treatment-resistant depression

Murphy Medical Associates today announced that Drive Thru testing for Novel Coronavirus SARS CoV2 and the disease COVID 19 will be offered at all locations.

According to a latest market report published by Persistence Market Research titled, ‘Global Disposable Plastic Blood Bags Market’, the market is projected to expand at a CAGR of 9.5% in terms of revenue over the forecast period (2016–2024). Excess Production of Disposable Blood Bags by Indian Manufacturers offers Major Potential to Export Blood Bags to Transitional Countries in Europe and MEA.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today the signing of a commercial agreement with Anasac Chile S.A. to develop and distribute GRANDEVO® Bioinsecticide and VENERATE® Bioinsecticide in Chile.

Myovant Sciences (NYSE: MYOV), today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of women with moderate to severe symptoms associated with uterine fibroids.

Daxor Corporation(NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the U.S. Air Force (USAF) has awarded Daxor a contract to define specifications to adapt blood volume analysis technology to meet the needs of USAF.

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Thomas C. Wessel, M.D., Ph.D., has been appointed the Company’s Executive Vice President and Head of Research and Development.